Automatic segmentation of kidney and kidney tumour in Computed Tomography (CT) images is essential, as it uses less time as compared to the current gold standard of manual segmentation. However, many hospitals are still reliant on manual study and segmentation of CT images by medical practitioners because of its higher accuracy. Thus, this study focuses on the development of an approach for automatic kidney and kidney tumour segmentation in contrast-enhanced CT images. A method based on Convolutional Neural Network (CNN) was proposed, where a 3D U-Net segmentation model was developed and trained to delineate the kidney and kidney tumour from CT scans. Each CT image was pre-processed before inputting to the CNN, and the effect of down-sampled and patch-wise input images on the model performance was analysed. The proposed method was evaluated on the publicly available 2021 Kidney and Kidney Tumour Segmentation Challenge (KiTS21) dataset. The method with the best performing model recorded an average training Dice score of 0.6129, with the kidney and kidney tumour Dice scores of 0.7923 and 0.4344, respectively. For testing, the model obtained a kidney Dice score of 0.8034, and a kidney
Chronic Kidney Disease (CKD) is one of the widespread Chronic diseases with no known ultimo cure and high morbidity. Research demonstrates that progressive Chronic Kidney Disease (CKD) is a heterogeneous disorder that significantly impacts kidney structure and functions, eventually leading to kidney failure. With the progression of time, chronic kidney disease has moved from a life-threatening disease affecting few people to a common disorder of varying severity. The goal of this research is to visualize dominating features, feature scores, and values exhibited for early prognosis and detection of CKD using ensemble learning and explainable AI. For that, an AI-driven predictive analytics approach is proposed to aid clinical practitioners in prescribing lifestyle modifications for individual patients to reduce the rate of progression of this disease. Our dataset is collected on body vitals from individuals with CKD and healthy subjects to develop our proposed AI-driven solution accurately. In this regard, blood and urine test results are provided, and ensemble tree-based machine-learning models are applied to predict unseen cases of CKD. Our research findings are validated after len
Chronic Kidney Disease (CKD) constitutes a major global medical burden, marked by the gradual deterioration of renal function, which results in the impaired clearance of metabolic waste and disturbances in systemic fluid homeostasis. Owing to its substantial contribution to worldwide morbidity and mortality, the development of reliable and efficient diagnostic approaches is critically important to facilitate early detection and prompt clinical management. This study presents a deep convolutional neural network (CNN) for early CKD detection from CT kidney images, complemented by class balancing using Synthetic Minority Over-sampling Technique (SMOTE) and interpretability via Gradient-weighted Class Activation Mapping (Grad-CAM). The model was trained and evaluated on the CT KIDNEY DATASET, which contains 12,446 CT images, including 3,709 cyst, 5,077 normal, 1,377 stone, and 2,283 tumor cases. The proposed deep CNN achieved a remarkable classification performance, attaining 100% accuracy in the early detection of chronic kidney disease (CKD). This significant advancement demonstrates strong potential for addressing critical clinical diagnostic challenges and enhancing early medical i
Kidneys are the filter of the human body. About 10% of the global population is thought to be affected by Chronic Kidney Disease (CKD), which causes kidney function to decline. To protect in danger patients from additional kidney damage, effective risk evaluation of CKD and appropriate CKD monitoring are crucial. Due to quick and precise detection capabilities, Machine Learning models can help practitioners accomplish this goal efficiently; therefore, an enormous number of diagnosis systems and processes in the healthcare sector nowadays are relying on machine learning due to its disease prediction capability. In this study, we designed and suggested disease predictive computer-aided designs for the diagnosis of CKD. The dataset for CKD is attained from the repository of machine learning of UCL, with a few missing values; those are filled in using "mean-mode" and "Random sampling method" strategies. After successfully achieving the missing data, eight ML techniques (Random Forest, SVM, Naive Bayes, Logistic Regression, KNN, XGBoost, Decision Tree, and AdaBoost) were used to establish models, and the performance evaluation comparisons among the result accuracies are measured by the
This paper assesses whether using clinical characteristics in addition to imaging can improve automated segmentation of kidney cancer on contrast-enhanced computed tomography (CT). A total of 300 kidney cancer patients with contrast-enhanced CT scans and clinical characteristics were included. A baseline segmentation of the kidney cancer was performed using a 3D U-Net. Input to the U-Net were the contrast-enhanced CT images, output were segmentations of kidney, kidney tumors, and kidney cysts. A cognizant sampling strategy was used to leverage clinical characteristics for improved segmentation. To this end, a Least Absolute Shrinkage and Selection Operator (LASSO) was used. Segmentations were evaluated using Dice and Surface Dice. Improvement in segmentation was assessed using Wilcoxon signed rank test. The baseline 3D U-Net showed a segmentation performance of 0.90 for kidney and kidney masses, i.e., kidney, tumor, and cyst, 0.29 for kidney masses, and 0.28 for kidney tumor, while the 3D U-Net trained with cognizant sampling enhanced the segmentation performance and reached Dice scores of 0.90, 0.39, and 0.38 respectively. To conclude, the cognizant sampling strategy leveraging th
Cardiovascular disease and chronic kidney disease are major complications of diabetes, leading to high morbidity and mortality. Early detection of these conditions is critical, yet traditional diagnostic markers often lack sensitivity in the initial stages. This study integrates conventional statistical methods with machine learning approaches to improve early diagnosis of CKD and CVD in diabetic patients. Descriptive and inferential statistics were computed in SPSS to explore associations between diseases and clinical or demographic factors. Patients were categorized into four groups: Group A both CKD and CVD, Group B CKD only, Group C CVD only, and Group D no disease. Statistical analysis revealed significant correlations: Serum Creatinine and Hypertension with CKD, and Cholesterol, Triglycerides, Myocardial Infarction, Stroke, and Hypertension with CVD. These results guided the selection of predictive features for machine learning models. Logistic Regression, Support Vector Machine, and Random Forest algorithms were implemented, with Random Forest showing the highest accuracy, particularly for CKD prediction. Ensemble models outperformed single classifiers in identifying high-ri
Determination of dietary food consumed a day for patients with diseases in general, greatly affect the health of the body and the healing process, is no exception for people with kidney disease and urinary tract. This paper presents the determination of diet composition in the form of food subtance for people with kidney and urinary tract diseases with a genetic fuzzy approach. This approach combines fuzzy logic and genetic algorithms, which utilizing fuzzy logic fuzzy tools and techniques to model the components of the genetic algorithm and adapting genetic algorithm control parameters, with the aim of improving system performance. The Mamdani fuzzy inference model and fuzzy rules based on population parameters and generation are used to determine the probability of crossover and mutation, and was using In this study, 400 food survey data along with their substances was used as test material. From the data, a varying amount of population is established. Each chromosome has 10 genes in which the value of each gene indicates the index number of foodstuffs in the database. The fuzzy genetic approach produces 10 best food substance and their compositions. The composition of these food
In vitro models play a crucial role in advancing our understanding of biological processes, disease mechanisms, and developing screening platforms for drug discovery. Kidneys play an instrumental role in transport and elimination of drugs and toxins. However, despite the well-established patient-to-patient differences in kidney function and disease manifestation, progression and prognostic, few studies take this variability into consideration. In particular, the discrepancies between female and male biology warrants a better representation within kidney in vitro models. The omission of sex as a biological variable poses the significant risk of overlooking sex-specific mechanisms in health and disease and potential differences in drug efficacy and toxicity between males and females. This review aims to highlight the importance of incorporating sex dimorphism in kidney in vitro models by examining the sexual characteristics in the context of the current state-of-the-art. Furthermore, this review underscores opportunities for improving kidney models by incorporating sex-specific traits. Ultimately, this roadmap to incorporating sex-dimorphism in kidney in vitro models will facilitate
Win statistics based methods have gained traction as a method for analyzing Hierarchical Composite Endpoints (HCEs) in randomized clinical trials, particularly in cardiovascular and kidney disease research. HCEs offer several key advantages, including increased statistical power, mitigation of competing risks, and hierarchical ranking of clinical outcomes. While, as summary measures, the win ratio (WR) along with the Net Benefit (NB) and the Win Odds (WO) provide a structured approach to analyzing HCEs, several concerns regarding their interpretability remain. In this paper, we present known issues with the WR using simple examples designed to explore the implications for the clinical interpretability of the treatment effect measure in the chronic kidney disease setting. Specifically, we discuss the challenge of defining an appropriate estimand in the context of HCEs using the WR, the difficulties in formulating a relevant causal question underlying the WR, and the dependency of the WR on the variance of its components, which complicates its role as an effect measure. Additionally, we highlight the non-collapsibility and non-transitivity of the WR, further complicating its interpre
Deep learning has become an extremely powerful tool for complex tasks such as image classification and segmentation. The medical industry often lacks high-quality, balanced datasets, which can be a challenge for deep learning algorithms that need sufficiently large amounts of data to train and increase their performance. This is especially important in the context of kidney issues such as for stones, cysts and tumors. We used deep learning models for this study to classify or detect several types of kidney diseases. We use different classification models, such as VGG-19, (CNNs) Convolutional Neural Networks, ResNet-101, VGG-16, ResNet-50, and DenseNet-169, which can be enhanced through techniques such as classification, segmentation, and transfer learning. These algorithms can help improve model accuracy by allowing them to learn from multiple datasets. This technique has the potential to revolutionize the diagnosis and treatment of kidney problems as it enables more accurate and effective classification of CT-scan images. This may ultimately lead to better patient outcomes and improved overall health outcomes.
Kidney structures segmentation is a crucial yet challenging task in the computer-aided diagnosis of surgery-based renal cancer. Although numerous deep learning models have achieved remarkable success in many medical image segmentation tasks, accurate segmentation of kidney structures on computed tomography angiography (CTA) images remains challenging, due to the variable sizes of kidney tumors and the ambiguous boundaries between kidney structures and their surroundings. In this paper, we propose a boundary-aware network (BA-Net) to segment kidneys, kidney tumors, arteries, and veins on CTA scans. This model contains a shared encoder, a boundary decoder, and a segmentation decoder. The multi-scale deep supervision strategy is adopted on both decoders, which can alleviate the issues caused by variable tumor sizes. The boundary probability maps produced by the boundary decoder at each scale are used as attention to enhance the segmentation feature maps. We evaluated the BA-Net on the Kidney PArsing (KiPA) Challenge dataset and achieved an average Dice score of 89.65$\%$ for kidney structure segmentation on CTA scans using 4-fold cross-validation. The results demonstrate the effective
Patients with acute kidney injury (AKI) are at high risk of developing chronic kidney disease (CKD), but identifying those at greatest risk remains challenging. We used electronic health record (EHR) data to dynamically track AKI patients' clinical evolution and characterize AKI-to-CKD progression. Post-AKI clinical states were identified by clustering patient vectors derived from longitudinal medical codes and creatinine measurements. Transition probabilities between states and progression to CKD were estimated using multi-state modeling. After identifying common post-AKI trajectories, CKD risk factors in AKI subpopulations were identified through survival analysis. Of 20,699 patients with AKI at admission, 3,491 (17%) developed CKD. We identified fifteen distinct post-AKI states, each with different probabilities of CKD development. Most patients (75%, n=15,607) remained in a single state or made only one transition during the study period. Both established (e.g., AKI severity, diabetes, hypertension, heart failure, liver disease) and novel CKD risk factors, with their impact varying across these clinical states. This study demonstrates a data-driven approach for identifying high
Rare diseases are collectively common, affecting approximately one in twenty individuals worldwide. In recent years, rapid progress has been made in rare disease diagnostics due to advances in DNA sequencing, development of new computational and experimental approaches to prioritize genes and genetic variants, and increased global exchange of clinical and genetic data. However, more than half of individuals suspected to have a rare disease lack a genetic diagnosis. The Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) Consortium was initiated to study thousands of challenging rare disease cases and families and apply, standardize, and evaluate emerging genomics technologies and analytics to accelerate their adoption in clinical practice. Further, all data generated, currently representing ~7500 individuals from ~3000 families, is rapidly made available to researchers worldwide via the Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) to catalyze global efforts to develop approaches for genetic diagnoses in rare diseases (https://gregorconsortium.org/data). The majority of these families have undergone prior clinical genetic testing
Paediatric kidney disease varies widely in its presentation and progression, which calls for continuous monitoring of renal function. Using electronic health records collected between 2019 and 2025 at Great Ormond Street Hospital, a leading UK paediatric hospital, we explored a temporal modelling approach that integrates longitudinal laboratory sequences with demographic information. A recurrent neural model trained on these data was used to predict whether a child would record an abnormal serum creatinine value within the following thirty days. Framed as a pilot study, this work provides an initial demonstration that simple temporal representations can capture useful patterns in routine paediatric data and lays the groundwork for future multimodal extensions using additional clinical signals and more detailed renal outcomes.
Fair regression methods have the potential to mitigate societal bias concerns in health care, but there has been little work on penalized fair regression when multiple groups experience such bias. We propose a general regression framework that addresses this gap with unfairness penalties for multiple groups. Our approach is demonstrated for binary outcomes with true positive rate disparity penalties. It can be efficiently implemented through reduction to a cost-sensitive classification problem. We additionally introduce novel score functions for automatically selecting penalty weights. Our penalized fair regression methods are empirically studied in simulations, where they achieve a fairness-accuracy frontier beyond that of existing comparison methods. Finally, we apply these methods to a national multi-site primary care study of chronic kidney disease to develop a fair classifier for end-stage renal disease. There we find substantial improvements in fairness for multiple race and ethnicity groups who experience societal bias in the health care system without any appreciable loss in overall fit.
Kidney stone disease poses a major burden to patients and healthcare systems around the world. The formation of kidney stones may occur over months or years, but many patients are diagnosed at a late stage, suffer excruciating pain, and require surgical intervention to physically remove the stones. The prevalence of kidney stones has increased during recent decades to over 10% in many developed countries, suggesting a link with environmental and behavioral factors. Recurrence rates are also high. In terms of their impact and scale, kidney stones are an ongoing pandemic. The causes and mechanisms of kidney stone formation are diverse and often unknown, resulting in varied compositions and different anatomical locations being affected. A better understanding of these processes could enable earlier diagnoses through more sensitive and scalable biomarkers, as well as more effective preventives and therapeutics.
With Polycystic Kidney Disease (PKD) potentially leading to fatal complications in patients due to the formation of cysts in kidneys, early detection of PKD is crucial for effective management of the condition. However, the various patient-specific factors that play a role in the diagnosis make it an intricate puzzle for clinicians to solve, leading to possible kidney failure. Therefore, in this study we aim to utilize a deep learning-based approach for early disease detection through gene expression analysis. The devised neural network is able to achieve accurate and robust prediction results for possible PKD in kidneys, thereby improving patient outcomes. Furthermore, by conducting a gene ontology analysis, we were able to predict the top gene processes and functions that PKD may affect.
Automated segmentation of kidneys and kidney tumors is an important step in quantifying the tumor's morphometrical details to monitor the progression of the disease and accurately compare decisions regarding the kidney tumor treatment. Manual delineation techniques are often tedious, error-prone and require expert knowledge for creating unambiguous representation of kidneys and kidney tumors segmentation. In this work, we propose an end-to-end boundary aware fully Convolutional Neural Networks (CNNs) for reliable kidney and kidney tumor semantic segmentation from arterial phase abdominal 3D CT scans. We propose a segmentation network consisting of an encoder-decoder architecture that specifically accounts for organ and tumor edge information by devising a dedicated boundary branch supervised by edge-aware loss terms. We have evaluated our model on 2019 MICCAI KiTS Kidney Tumor Segmentation Challenge dataset and our method has achieved dice scores of 0.9742 and 0.8103 for kidney and tumor repetitively and an overall composite dice score of 0.8923.
Chronic kidney disease (CKD) is a significant public health challenge, often progressing to end-stage renal disease (ESRD) if not detected and managed early. Early intervention, warranted by silent disease progression, can significantly reduce associated morbidity, mortality, and financial burden. In this study, we propose a novel approach to modeling CKD progression using a combination of machine learning techniques and classical statistical models. Building on the work of Liu et al. (2023), we evaluate linear models, tree-based methods, and deep learning models to extract novel predictors for CKD progression, with feature importance assessed using Shapley values. These newly identified predictors, integrated with established clinical features from the Kidney Failure Risk Equation, are then applied within the framework of Cox proportional hazards models to predict CKD progression.
Randomized controlled trials (RCTs) are the standard for evaluating the effectiveness of clinical interventions. To address the limitations of RCTs on real-world populations, we developed a methodology that uses a large observational electronic health record (EHR) dataset. Principles of regression discontinuity (rd) were used to derive randomized data subsets to test expert-driven interventions using dynamic Bayesian Networks (DBNs) do-operations. This combined method was applied to a chronic kidney disease (CKD) cohort of more than two million individuals and used to understand the associational and causal relationships of CKD variables with respect to a surrogate outcome of >=40% decline in estimated glomerular filtration rate (eGFR). The associational and causal analyses depicted similar findings across DBNs from two independent healthcare systems. The associational analysis showed that the most influential variables were eGFR, urine albumin-to-creatinine ratio, and pulse pressure, whereas the causal analysis showed eGFR as the most influential variable, followed by modifiable factors such as medications that may impact kidney function over time. This methodology demonstrates